Showing results (1711-1720 of 1,820) with videos related to
Sort By:
Pageof 182
Clinical Orthopaedics and Related Research|January 3, 2019
Failure of Indomethacin and Radiation to Prevent Blast-induced Heterotopic Ossification in a Sprague-Dawley Rat ModelAstor D Robertson, Alexander M Chiaramonti, Thao P Nguyen, et al.Environmental Science & Technology|July 27, 2011
Prevalence of anaerobic ammonium-oxidizing bacteria in contaminated groundwaterTara A Moore, Yangping Xing, Brent Lazenby, et al.Nucleic Acids Research|July 26, 2011
Targeted bisulfite sequencing by solution hybrid selection and massively parallel sequencingEun-Joon Lee, Lirong Pei, Gyan Srivastava, et al.Plos Pathogens|July 7, 2023
An acidic microenvironment in Tuberculosis increases extracellular matrix degradation by regulating macrophage inflammatory responsesAshley M Whittington, Frances S Turner, Friedrich Baark, et al.Molecular Oncology|July 7, 2023
SETD2 loss in renal epithelial cells drives epithelial-to-mesenchymal transition in a TGF-β-independent mannerTianchu Wang, Ryan T Wagner, Ryan A Hlady, et al.The Journal of Thoracic and Cardiovascular Surgery|September 23, 2008
Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survivalJoseph C Cleveland, Frederick L Grover, David A Fullerton, et al.Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 30, 1998
Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of NeurologyS Gilman, P Low, N Quinn, et al.Journal of Neuropathology and Experimental Neurology|September 27, 2000
Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophyJ E Duda, B I Giasson, T L Gur, et al.Neurologia (Barcelona, Spain)|December 29, 1999
[Consensus on the diagnosis of multi-system atrophy]S Gilman, P Low, N Quinn, et al.Archives of Internal Medicine|July 19, 2002
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trialScott M Grundy, Gloria Lena Vega, Mark E McGovern, et al.Pageof 182